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CObjectives: The objective of this study was to estimate the time to
breakeven and 5-year net costs of laparoscopic adjustable gastric band-
ing (LAGB) taking both direct and indirect costs and cost savings into
account. Methods: Estimates of direct cost savings from LAGB were
vailable from the literature. Although longitudinal data on indirect
ost savings were not available, these estimates were generated by
uantifying the relationship betweenmedical expenditures and absen-
eeism and between medical expenditures and presenteeism (reduced
n-the-job productivity) and combining these elasticity estimates with
stimates of the direct cost savings to generate total savings. These
avings were then combined with the direct and indirect costs of the
rocedure to quantify net savings. Results: By including indirect costs,
he time to breakeven was reduced by half a year, from 16 to 14 quar-
ers. After 5 years, net savings in medical expenditures from a gastric O
ate M
al So
oi:10.1016/j.jval.2011.12.004anding procedure were estimated to be $4970 ($3090). Including ab-
enteeism increased savings to $6180 ($3550). Savings were further
ncreased to $10,960 ($5864) when both absenteeism and presentee-
sm estimateswere included.Conclusions: This studypresentedanovel
pproach for including absenteeism and presenteeism estimates in cost-
enefit analyses. Application of the approach to gastric banding among sur-
ery-eligible obese employees revealed that the inclusion of indirect costs
nd cost savings improves the business case for the procedure. This ap-
roach can easily be extended to other populations and treatments.
eywords: bariatric surgery, business case, obesity, return on invest-
ent.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Recent evidence reveals that the direct (medical) and indirect (pro-
ductivity loss) burden of severe obesity, defined as having a body
mass index (BMI) greater than 40 kg/m2, is substantial [1]. Bahr et
al. [2] showed that annual obesity-attributable medical expendi-
tures for the severely obese could be as high as $1270 formales and
$2530 for females. Furthermore, they showed that the indirect
costs resulting from severe obesity, which include increased ab-
senteeism and health-related reductions in productivity while at
work (termed presenteeism), comprised an even larger share of
total obesity-attributable costs. They estimated annual indirect
obesity-attributable costs of $6090 for severely obese male em-
ployees and $6690 for severely obese female employees.
Because of the high costs resulting from severe obesity, effective
obesity interventionshave thepotential to generate significant savings.
To date, the most effective intervention for severe obesity is bariatric
surgery; the two most common types of bariatric surgery are gastric
bypass surgery and gastric banding. Both procedures have been shown
tobecost-effectivewhenfocusingondirectmedical expenditures [3–8].
Estimating changes in direct medical expenditures after a
medical/surgical intervention is easily accomplished because of
readily available longitudinal medical claims data. Similar data do
not exist for estimating indirect costs. As a result, nearly all cost-
effectiveness and cost-benefit studies focus solely on direct costs.
* Address correspondence to: Eric A. Finkelstein, Duke-NUS Gradu
E-mail: eric.finkelstein@duke-nus.edu.sg.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.Given that a bariatric procedure not only generates short-term
work loss but also has the potential to reduce subsequent absen-
teeism and presenteeism, the largest components of obesity-re-
lated costs, and because employers are ultimately responsible for
making coverage decisions for their employees, a lack of informa-
tion on potential indirect cost implications resulting frombariatric
procedures is a significant limitation.
The objective of this study was to estimate the time to
breakeven and 5-year net costs of laparoscopic adjustable gastric
banding (LAGB) taking both direct medical and indirect absentee-
ism and presenteeism costs and cost savings into account. Al-
though longitudinal data on indirect cost savings are not available,
indirect cost savings were generated by estimating the relation-
ship between medical expenditures and absenteeism and be-
tween medical expenditures and presenteeism and combining
these estimates with estimates of the direct cost savings. Al-
though the analysis focuses on LAGB as a treatment for severe
obesity, this approach can easily be applied to gastric bypass or
extended to other populations and treatments.
Methods
Methodological overview
The estimation strategy occurred in four steps. First, estimates of
quarterly percentage reductions in direct medical cost savings
edical School, 8 College Road, Singapore 169857.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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300 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 2 9 9 – 3 0 4post-LAGB (termed i, where i denotes the quarter postprocedure)
ere derived from published literature [9]. Second, an elasticity
as calculated that quantifies the percentage change in absentee-
sm for a given percentage change in medical expenditures
termed ). Multiplying each i times  allows for estimating quar-
erly percentage reductions in absenteeism postbanding. Third,
ecause no data set exists that allows for directly estimating the
ercentage change in presenteeism for a given percentage change
n medical expenditures, this estimate was calculated indirectly
y quantifying the percentage change in presenteeism for a given
ercentage change in absenteeism, termed . This estimate was
hen multiplied by  and then by each i to estimate quarterly
ercentage savings in presenteeism postprocedure. Fourth, all
avings were monetized and then combined with the direct and
ndirect costs of the procedure to quantify net costs. The data and
more detailed estimation approach are described below.
Data
Themedical expenditure/absenteeismelasticity () was estimated
y using the publicly available Medical Expenditure Panel Survey
MEPS)—a nationally representative survey of the civilian nonin-
titutionalized population that quantifies an individual’s total an-
ual medical spending by type of service and source of payment.
his includes all expenditures for office-based visits, hospital out-
atient visits, emergency room visits, hospital inpatient stays,
ome health care, dental care, vision aids, other medical equip-
ent and services (e.g., orthopedic items,medical equipment, dis-
osable supplies), andprescription medicines. The survey also in-
ludes the following question in each interview round that allows
or quantifying annual work loss due to illness or injury: “How
any days did [respondent]miss a half day ormore of work due to
ealth problems?”
Other questions capture employment status, self-reported
eight and height, and sociodemographic characteristics of re-
pondents. The MEPS sample was limited to full-time, nonpreg-
ant employees between the ages of 18 and 64 years (N  18,143).
or the primary analysis, the sample was further limited to those
ligible for bariatric surgery, which includes those with a BMI of
ore than 40 or between 35 and 40 with a significant comorbidity,
ncluding sleep apnea, cardiovascular disease, osteoarthritis, or
iabetes (n 876), and to those respondentswith data in both 2005
nd 2006 (n  134 individuals representing 268 observations). To
auge the sensitivity of the elasticity estimate to sample selection,
upplemental analyses were conducted on the larger samples.
MEPS does not include questions on presenteeism. Both absen-
eeism and presenteeism, however, are included in the proprie-
ary National Health and Wellness Survey (NHWS), although it
oes not capturemedical expenditures. Therefore, the 2008NHWS
ross-sectional data set was used to quantify the absenteeism/
resenteeism elasticity (). NHWS is a self-administered, Internet-
ased questionnaire that focuses on the health status and health-
are attitudes, behaviors, and outcomes of adults aged 18 years or
lder. It is fielded to 63,000 members of an Internet-based con-
umer panel and is designed to be representative of the US adult
opulation. NHWS captures absenteeism and presenteeism by us-
ng the Work Productivity and Activity Impairment (WPAI) index.
The WPAI index is a validated questionnaire, commonly used
cross various occupations and disease areas to assess employee
roductivity losses related to health [10]. Absenteeism is mea-
ured by using the following question: “During the past seven
ays, how many hours did you miss from work because of your
ealth problems?” Presenteeism is assessed with the following
uestion, “During the past seven days, howmuch did your health
roblems affect your productivity while you were working?” Par-
icipants indicate their level of work impairment via a rating scale
anging from 0 to 10, with 0 indicating that “health problems had
o effect on my work” and 10 indicating that “health problemsompletely prevented me from working.” Each response is as-
umed to represent a percentage reduction in productivework due
o health problems (e.g., a respondent reporting a value of 3 is
ssumed to have a 30% reduction in productive work, whereas a
espondent reporting a 10 is assumed to be completely unproduc-
ive while at work).
NHWS also includes questions similar to those in MEPS that
apture self-reported height and weight, employment status, and
ther sociodemographic characteristics. Other than the require-
ent of being in two consecutive years of data (data for only 1 year
ere available for the analysis), the same sample restrictionswere
pplied as for the MEPS data. The primary analysis sample in-
luded 2164 individualswhowere full-time employees and eligible
or LAGB; supplemental analyses were run on the larger sample.
Estimation of indirect costs
MEPS provides annual estimates formedical expenditures and ab-
senteeism. To annualize the WPAI index data, each respondent’s
absenteeism estimatewas divided by 8 (to convert it fromhours to
days) andmultiplied by 50, the estimated number ofworkweeks in
a year. The presenteeism percentage was multiplied by 250 (the
number ofworkdays per year) to estimate the number ofworkdays
per year that the individual was unproductive at work due to
health problems.
Using the annualized values for medical expenditures, absen-
teeism, and presenteeism, regression modules of the following
form were used to estimate the elasticities:
logABSi  logMEDi Zii
logPRESi  logABSi Zi	i
The log-log specification has the advantage that the coeffi-
cients on log(MEDi) and log(ABSi) are estimated elasticities. In the
MEPS model, with annual absenteeism days as the dependent
variable and annualmedical expenditures as the key independent
variable, this coefficient is a direct estimate of , the percentage
change in absenteeism for a given percentage change in medical
expenditures. In the NHWS model, with annual presenteeism
days as the dependent variable and annual absenteeism days as
the key independent variable, this coefficient provides an estimate
of ; multiplying this estimate times  provides an estimate of the
percentage change in presenteeism for a given percentage change
in medical expenditures.
Although the log-log model is a convenient method for esti-
mating elasticities, it is problematic when the logged variables
include a large percentage of zeros, aswas the case for themedical
expenditures, absenteeism, and presenteeism variables. To en-
sure that individuals with zeros for these variables were not
dropped from the models, in the primary specification 0.1 days
were added to all zero absenteeism and presenteeism days and $1
was added for all individuals who had no medical expenditures
during the year. Supplemental analyses—which included 1) anal-
yses on only those with positive values for these variables, 2) gen-
eralized linear models that did not require log transformations,
and 3) larger adjustment factors—tested the robustness of this
approach. We also explored the effects of not restricting the re-
gressions to the surgery-eligible population.
All regressions also included the following control variables:
age, sex (female indicator), and race/ethinicity (non-Hispanic
white, Hispanic white, black [Hispanic and non-Hispanic], other).
For the MEPS regression, individual fixed-effects models were
used to control for unobservable time-invariant characteristics of
individuals. Because only 1 year of data were available for the
NHWS regression, a traditional ordinary least squares model was
used to estimate .
The estimates of  and  and estimates of  were combined asi
noted in the “Methodological Overview” section to generate quar-
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301V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 2 9 9 – 3 0 4terly percentage savings in absenteeism and presenteeism. To
convert these percentage savings into dollars, these values were
multiplied by the absenteeism and presenteeism costs attribut-
able to obesity among the surgery-eligible population. These esti-
mateswere generated by using theNHWSdata following the iden-
tical approach presented in Finkelstein et al. [11], with the only
difference being that the obesity category variable was redefined
to include only those individuals who were obese and eligible for
bariatric surgery (as defined above).
The quarterly monetized savings in absenteeism and presen-
teeism postbanding were then combined with the direct medical
cost savings to estimate total quarterly savings resulting from an
LAGB procedure. These savings were combined with the direct
and indirect costs of the procedure to estimate time to breakeven
and net costs at the end of 5 years. Direct costs for an LAGB pro-
cedure were taken directly from Finkelstein et al. [12]. Work-loss
estimates were taken from Fisher [13] andmonetized by using the
approach presented in Finkelstein et al. [11].
Fisher reports that the average number of days prior to return-
ng to normal activity was 7.2 and that 15.8 days were required for
full recovery. These were converted into 5.2 days of absenteeism
7.2 minus 2 weekend days) and 3.3 days of presenteeism. The
resenteeism estimate was calculated by taking 15.8 days and
ubtracting out 7.2 days of absenteeism, two additional weekend
ays, and assuming that patients are working at 50% productivity
or the 6.6 days prior to full recovery.
Confidence intervals for the net cost estimates were generated
y combining each of 1000 bootstrapped iterations from the direct
ost estimates with a random draw from the preferred model
pecification from the absenteeism and presenteeism estimates
ssuming a bivariate normal distribution with means equal to the
stimated elasticities, variances equal to the square of the esti-
ated standard errors from the corresponding regression model,
nd covariance based on the estimated standard errors and an
ssumed correlation of r 0.5. We also conducted additional sen-
sitivity analyses for the time to breakeven by using the extreme
values of  and  generated from the alternative regressionmodels
nd using the primary estimates but assuming the two elasticity
stimates are 1) uncorrelated or 2) perfectly correlated (r  1.0).
Results
Table 1 presents summary statistics for theMEPS and NHWS sam-
les used in the primary analysis. The two samples have similar
ge and gender profiles. Likely because it is an Internet panel, the
HWS sample includesmorewhites and fewer blacks andHispan-
cs. The average BMI among the surgery-eligible sample is also
lightly larger in MEPS than in NHWS, 44.1 (standard error [SE] 
.4) versus 42.9 (SE  0.1). MEPS respondents who are eligible for
bariatric surgery report $4050 (SE 790) in annual medical expen-
ditures. They also report, on an annualized basis, an average of 7.7
days (SE  1.9) where at least a half-day or more of work was
missed because of health problems. However, 12% and 39% of the
observations included zeros for medical expenditures and work
loss, respectively.
Annualized estimates of absenteeism among the surgery-eligi-
ble NHWS sample revealed 14.7 days (SE  1.0) of work loss on
average, with 37% of individuals missing zero days. This estimate
is more than double the MEPS estimate. This difference likely re-
sults from differences in how the question was asked. NHWS cap-
tureswork loss of less thanhalf a day,whereasMEPS does not. The
average number of presenteeism days for a surgery-eligible indi-
vidual in NHWS was 58.0 (SE  1.4), with 55% reporting zero pre-
senteeism days. Using the approach presented in Finkelstein et al.
[11], when limited to obesity-attributable work loss among the
surgery-eligible population, the annual obesity-attributable ab-
senteeism and presenteeism estimates are reduced to 7.0 daysand 21.0 days, respectively. Whenmonetized, this equates to $620
per quarter for absenteeism and $1870 per quarter for presentee-
ism.
Column 1 of Table 2, reprinted from Finkelstein et al. [12], pres-
ents average quarterly savings post-LAGB. Dividing these savings by
costs for the control group in the corresponding quarter generated
the estimated is. The average percentage savings (relative to the
ontrol group) post–gastric banding are 38%, with estimates ranging
rom 27% (quarter 3) to 63% (quarters 15 through 20 pooled).
Table 3 presents estimates , , and  times . The estimate of ,
which represents the percentage change in absenteeism for a given
percentage change inmedical expenditures, from the primary spec-
ification is 0.31, meaning that, for example, a 10% decrease in medi-
cal expenditures inagivenquarterwouldgeneratea3.1%decrease in
quarterly absenteeism costs. Variousmodel specifications and sam-
ples lead to estimates of  between 0.24 and 0.57.
The estimate of , the percentage change in presenteeism for a
iven percentage change in absenteeism, from the primary spec-
fication was 0.49, with estimates ranging from 0.12 to 0.58. Multi-
lying  times  provides an estimate of the percentage change in
presenteeism for a given percentage change in medical expendi-
tures. Using the primary estimates of  times  yields an estimate
of 0.15 (0.31 0.49), revealing that, following the example above, a
10% reduction in quarterly medical expenditures would yield a
1.5% reduction in quarterly presenteeism costs.
Finkelstein et al. [12] reported that the direct medical cost of a
gastric banding procedure is $20,030.Monetizing the indirect costs
reported in Fisher [13] and applying the assumptions presented
Table 1 – Summary statistics for individuals eligible for
LAGB in the Medical Expenditure Panel Survey (MEPS)
and the National Health and Wellness Survey (NHWS).
MEPS (n  134) NHWS (n  2164)
Age (y), mean (SE) 43.2 (1.1) 44.7 (0.2)
Male (%) 49.3 49.1
Race (%)
White [reference] 61.5 67.8
Black 20.1 16.4
Hispanic 14.5 9.9
Asian 0.0 1.0
Other 3.9 4.9
Body mass index (kg/m2),
mean (SE)
44.1 (0.4) 42.9 (0.1)
Percentage with zero
medical
expenditures
12 N/A
Absenteeism days,* mean
(SE)
7.7 (1.9) 14.7 (1.0)
Percentage with zero
absenteeism days
39 37
Presenteeism days, mean
(SE)
N/A 58.0 (1.4)
Percentage with zero
presenteeism days
N/A 55.0
LAGB, laparoscopic adjustable gastric banding; N/A, not applicable/
available; SE, standard error.
* Absenteeism is measured differently in MEPS and NHWS. MEPS
includes the following question in each interview round that al-
lows for quantifying annual work loss due to illness or injury:
“Howmany days did [respondent]miss a half day ormore of work
due to health problems?” Absenteeism is measured in NHWS us-
ing the following question: “During the past seven days, how
many hours did youmiss fromwork because of your health prob-
lems?” These estimates were then annualized.above to split the costs between absenteeism and presenteeism
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302 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 2 9 9 – 3 0 4generated indirect cost estimates of $1900 and $1280, respectively,
suggesting that the total cost associated with a gastric banding
procedure is $23,210. Table 4 combines these cost estimates with
estimates of the is, , and  and the obesity-attributable costs in
the absence of the procedure to generate net savings in each quar-
ter resulting from gastric banding.
Column 1 of Table 4, reproduced from Finkelstein et al. [12],
presents the net costs of LAGB when focusing solely on direct
medical expenditures. These data reveal that the costs of the pro-
cedure are recovered in 16 quarters (4 years) when focusing solely
on direct medical expenditures. Column 2 provides results for
medical and absenteeism costs combined. When focusing on
these cost drivers only, the time to breakeven remains at 16 quar-
ters; reductions in absenteeism over this time period are exactly
offset by the number of days missed required to obtain the proce-
dure. Column 3 presents results for medical, absenteeism, and
presenteeism costs combined. Using all three cost categories, the
time to breakeven is reduced by half a year, from 16 to 14 quarters.
Best-case estimates of  and  reduce the time to breakeven to 13
uarters. Using the Fisher et al. estimates of work loss resulting
Table 2 – Quarterly savings in medical expenditures post-L
Quarter relative to
band placement
Quarterly reduction in medical
expenditures* (95% CI)†
2 590 (910 to 270)
3 380 (690 to 80)
4 670 (1000 to 340)
5 1210 (2160 to 260)
6 1510 (2050 to 970)
7 810 (1390 to 230)
8 880 (1550 to 210)
9 1160 (1870 to 450)
10 2170 (3550 to 790)
11 3090 (4560 to 1620)
12 1590 (2790 to 390)
13 1780 (3510 to 50)
14 2820 (5640 to 0)
15–19 (pooled) 1140 (1510 to 770)
CI, confidence interval; LAGB, laparoscopic adjustable gastric bandin
* LAGB procedure occurs on day 1 of quarter 1.
† Confidence intervals based on 1000 bootstrapped iterations of the
‡ Percentage reduction in medical expenditures relative to control g
Table 3 – Estimates of the elasticity between medical expe
Panel Survey (MEPS) and the elasticity between absenteeis
Survey (NHWS).
Estimate Percentage c
absenteeism
given perce
change in m
expenditu
Preferred model specification (95% CI) 0.31 (0.22–
Range based on alternate model specifications [0.24–0.4
CI, confidence interval; OLS, ordinary least squares.
* Estimate is based on 1000 simulations drawn from the sample mea
correlation of 0.5 between  and .
† The lower bound estimate is from the fixed effects full sample regre
bound estimate is from the cross-sectional OLS model after simila
‡ The lower bound estimate is from the OLS model on the surgery-elfrom the OLS model on the full sample after adjusting zero values as inrom the procedure, worst-case estimates suggest that the time to
reakeven remains at 16 quarters.
Although inclusion of absenteeism and presenteeism costs
as only a modest effect on time to breakeven, beyond the
reakeven period estimated savings are much larger when in-
irect costs are considered. Focusing on 5-year savings, Finkel-
tein et al. [12] reported net savings in medical expenditures
rom a gastric banding procedure to be $4970 ($3090). Includ-
ng absenteeism costs increases net savings to $6180 ($3550).
avings are further increased to $10,960 ($5864) when all three
ost categories are included.
Discussion
As noted in the Introduction, indirect costs are the single largest
driver of the costs of obesity, yet, because of data limitations, these
costs are typically omitted from cost-effectiveness and cost-ben-
efit analyses of obesity interventions. Given that employers bear a
large share of the indirect costs of obesity and are ultimately re-
.
Percentage reduction in medical expenditures relative to
control group (i)
‡ (95% CI)
36 (30–42)
27 (20–34)
31 (24–38)
35 (19–51)
37 (27–47)
23 (10–36)
24 (9–39)
28 (12–44)
43 (22–64)
50 (33–67)
42 (21–63)
37 (7–67)
53 (20–86)
63 (36–90)
cost data.
is generated from results presented in Hammond [9].
res and absenteeism from the Medical Expenditure
d presenteeism from the National Health and Wellness
e in
a
e
al
)
Percentage change in
presenteeism for a
given percentage
change in
absenteeism ()
Percentage change in
presenteeism for a
given percentage
change in medical
expenditures (  )
0.49 (0.43–0.55)* 0.15 (0.005–0.33)*
[0.12–0.58]‡ [0.03–0.33]
variance of  and  assuming a bivariate normal distribution with a
after adjusting zero values as in the primary specification. The upper
stment for zero values.
sample without adjusting zero values. The upper bound estimate isAGB
g.
directnditu
m an
hang
for
ntag
edic
res (
0.39)*
1]†
n and
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igiblethe primary specification.
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303V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 2 9 9 – 3 0 4sponsible for making coverage decisions for their employees, this
omission represents a significant limitation.
This analysis presented a novel strategy for estimating indirect
cost savings in the absence of longitudinal data pre- and postint-
ervention. The approach relied on estimating the relationship be-
tween changes in medical expenditures and corresponding
changes in absenteeism and presenteeism. Implementation is-
sues aside, the logic behind the approach is straightforward. In-
terventions that improve health should simultaneously reduce
medical expenditures, which can be directly assessed via longitu-
dinal claims data, and generate indirect cost savings through re-
ductions in absenteeism and presenteeism, which can be indi-
rectly quantified by estimating the relationship between changes
in medical expenditures and changes in absenteeism and presen-
teeism.
Application of this approach to estimate the net costs of gastric
banding revealed a high correlation between medical expendi-
tures, absenteeism, and presenteeism among the surgery-eligible
obese population. Finkelstein et al. [12] estimated an average quar-
erly savings postbanding of 38% ($1400). Based on this value and
he elasticity estimates presented in the preceding section, these
esults reveal average quarterly indirect cost savings of 12.2%
$390) and 6.0% ($70) for absenteeism and presenteeism, respec-
ively. When indirect costs are included, the estimated time to
reakeven is reduced from 4 to 3.5 years and the potential savings
o employers beyond this period are greatly increased. These re-
ults showa 222% increase in the 5-year savings alone, from$4,950
o $10,960, highlighting the importance of incorporating indirect
osts into the analysis.
As noted in the direct cost manuscript upon which these esti-
ates are based, much of the savings in direct costs were gener-
ted through lower use of inpatient services and, to a lesser extent,
ower payments for prescription drugs partly as a result of reduc-
ions in the use of diabetes medications [12]. Although the rela-
ionship between medical expenditures and absenteeism and
resenteeism was estimated by using cross-sectional data,
ower use of inpatient services would be expected to lead to less
ork loss, suggesting that the estimated relationships are in-
Table 4 – Net costs and time to breakeven post-LAGB.
Quarter Medical expenditures
only (95% CI)
1 $1030 (750–1310)
1 $20,030 (19,750–20,310)
2 $19,440 (18,940–19,940)
3 $19,060 (18,400–19,720)
4 $18,390 (17,600–19,180)
5 $17,180 (16,220–18,140)
6 $15,670 (14,460–16,880)
7 $14,860 (13,390–16,330)
8 $13,980 (12,250–15,710)
9 $12,820 (10,760–14,880)
10 $10,650 (7860–13,440)
11 $7560 (3800–11,320)
12 $5970 (1640–10,300)
13 $4190 (790 to 9170)
14 $1370 (4720 to 7460)
15 $230 (5880 to 6340)
16 $910 (7030 to 5210)
* Confidence intervals were generated by combining each of 1000 bo
from the preferred model specification from the absenteeism and
means equal to the estimated elasticities, variances equal to the sq
model, and covariance based on the estimated standard errors andernally consistent. The net savings are also consistent with theedical literature. A recent review of several prior meta-anal-
ses of LAGB reports that all studies reporting on comorbidities
howed significant resolution or improvement of type 2 diabe-
es mellitus, hypertension, and dyslipidemia. Sleep apnea was
lso significantly improved [14].
Although this study has much strength, there are some limita-
ions. One limitation is that the results hinge on obtaining unbi-
sed estimates of quarterly savings in direct medical expendi-
ures. These estimates are based on data obtained from the
arketScan® Commercial Claims and Encounters Database be-
ween January 1, 2003, and March 31, 2008 [15]. The database in-
luded full claims from approximately 100 large payers represent-
ng millions of covered lives. Moreover, a supplemental database
llowed for an identification of a subset of individuals who had a
elf-reported BMI of more than 35 kg/m2 in a health risk assess-
ment. This supplement was used to identify a sample of surgery-
eligible patients who, after propensity score matching, were used
as a control group. The longitudinal nature of the data and the
ability to merge BMI data make this one of the few data sets avail-
able for conducting this type of analysis. The results, however,
may not generalize beyond members of these health plans. More-
over, any biases in the direct cost estimates will be exacerbated
when indirect costs are included because the indirect cost savings
are a function of the savings in direct costs. In addition, both ab-
senteeism and presenteeism were based on self-report; objective
measures of these values would be preferable.
It would also be preferable to estimate the relationship be-
tween medical expenditures, absenteeism, and presenteeism by
using longitudinal data; however, only 2 years of MEPS data and 1
year of NHWS data were available. Moreover, because the two
elasticity estimates  and  were estimated from separate data
ets, we could not directly estimate their covariance. In reality, the
lasticities are likely to be positively correlated because medical
xpenditures, absenteeism, and presenteeismare all driven by the
nderlying health of the individual. To account for this, we as-
umed a correlation of 0.5 between  and  when estimating the
standard errors for the 5-year net savings estimates. This assump-
tion does not affect the point estimates, but it does affect the
ical expenditures 
absenteeism
(95% CI)*
Medical expenditures 
absenteeism 
presenteeism (95% CI)*
$1080 (770–1390) $1190 (800–1580)
21,930 (21,310–22,550) $23,210 (22,550–23,870)
21,200 (20,410–21,990) $22,200 (21,330–23,070)
20,710 (19,770–21,650) $21,500 (20,360–22,640)
19,920 (18,820–21,020) $20,470 (19,010–21,930)
18,570 (17,394–19,750) $18,850 (17,000–20,700)
16,910 (15,460–18,360) $16,920 (14,580–19,260)
16,010 (14,310–17,710) $15,850 (13,140–18,560)
15,040 (13,050–17,030) $14,690 (11,550–17,830)
13,770 (11,480–16,070) $13,220 (7860–18,580)
11,440 (8460–14,420) $10,570 (6100–15,040)
$8160 (4270–12,050) $6930 (1360–12,500)
$6420 (2020–10,820) $4880 (1380 to 11,140)
$4500 (560 to 9560) $2690 (4370 to 9750)
$1480 (4840 to 7800) $700 (9110 to 7710)
$110 (6290 to 6510) $2510 (11,370 to 6350)
$1250 (7769 to 5269) $4310 (13,680 to 5060)
apped iterations from the direct cost estimates with a random draw
enteeism estimates assuming a bivariate normal distribution with
of the estimated standard errors from the corresponding regression
rrelation equal to 0.5.Med
$
$
$
$
$
$
$
$
$
$
otstr
pres
uarestandard errors. If the estimates of  and  were perfectly corre-
304 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 2 9 9 – 3 0 4lated (r  1), then the standard error for the 5-year net savings
would increase by 29%, whereas if  and  were uncorrelated, the
standard error would be 26% smaller.
Finally, there are several sources of uncertainty that our esti-
mates do not take into account. The primary estimates report
standard errors based on uncertainty in the direct cost estimates
and the estimated elasticities. We also present sensitivity analy-
ses to gauge the impact of different sample and modeling strate-
gies on the results. Additional sources of uncertainty, such as vari-
ation in absenteeism and presenteeism time resulting from the
initial LAGB procedure, however, were not considered. To address
these limitations, long-term registries or clinical trials of LAGB
patients should incorporate routine data collection of all these
outcomes in a single comprehensive data set. Including additional
measures of burden, such as care giving and transportation costs,
would allow for a more accurate accounting of the net costs of
LAGB.
Conclusions
This study presented a novel approach for estimating indirect
costs savings when savings in direct costs are available. Applica-
tion of the approach to gastric banding among surgery-eligible
obese employees revealed that inclusion of indirect costs im-
proves the business case for the procedure. Future studies should
attempt to validate this approach by comparing the results to
those generated from longitudinal data postintervention, and, if
successful, apply it to other populations and treatments where
data on indirect cost savings are not readily available.
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